September 05, 2025

Dr. Jordan Strom Lays the Scene for ASE 2025

As ASE marks its 50th anniversary in Nashville, the meeting will showcase the latest echocardiography research, updated guidelines, the Kalmanson Lecture, and discussions on workforce challenges.

Conexiant

September 05, 2025

AI Tops Guidelines in Classifying Aortic Stenosis

Gradient-boosted model shows higher diagnostic accuracy—especially for severe AS—in low-flow cases where guideline-based metrics often yield discordant results.

Conexiant

September 05, 2025

AI-ECG Versus Echo: Which Wins for HF?

Novel electrocardiography tool grades diastolic dysfunction when standard imaging falls short.

Conexiant

September 05, 2025

CT Scans Rival Echo for Aortic Stenosis

CT angiographic imaging shows near-perfect accuracy in detecting valve disease.

Conexiant

September 03, 2025

Miami Brain Symposium, Eighth Annual

The Miami Brain Symposium will focus on state-of-the-art approaches to the management of primary and metastatic central nervous system tumors, along with current standards of care and a look at future directions. This symposium will engage participants as the expert faculty navigate through complex cases, novel treatment strategies and panel discussions.

Baptist Health South Florida

June 10, 2025

Does Combination Therapy Improve Albuminuria?

Finerenone plus empagliflozin reduced urinary albumin-to-creatinine ratio by 29% to 32% more than either drug alone in patients with chronic kidney disease and type 2 diabetes.

Conexiant

April 25, 2025

Head and Neck, Breast, Lung and Survivorship Studies Headline Dana-Farber Research at AACR Annual Meeting 2025

Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck cancer, metastatic breast cancer and lung cancer.

Dana-Farber

August 04, 2025

New Guidelines Recommend Blood-Based Biomarkers in Alzheimer's Dx

"The panel urges clinicians to consider the pretest probability of AD pathology for each patient when deciding whether or not to use a BBM test,” and not as a standalone diagnostic tool.

Conexiant

June 03, 2025

FDA Grants Breakthrough Status to Shield Test

The methylation-based blood assay is designed for screening multiple cancer types.

Conexiant